A series of novel N-aryl-4-[6-(2-fluoropyridin-3-yl)quinazolin-2-yl]-piperazine-1-carboxamide or -carbothioamide derivatives was synthesized by cyclization of 5-bromo-2-fluorobenzaldehyde and guanidine carbonate in the presence of dimethylacetamide followed by treatment with isoamylnitrite and diiodomethane in the presence of copper iodide to afford 6-bromo-2-iodoquinazoline. The latter was treated with piperazine in the presence of triethylamine followed by (2-fluoropyridin-3-yl)boronic acid in the presence of Pd(PPh3)2Cl2 to afford 6-(2-fluoropyridin-3-yl)-2-(piperazin-1-yl)quinazoline which was further treated with various substituted arylisocyanates and arylisothiocyanates to obtain the title compounds. The chemical structures of the synthesized compounds were confirmed by means of LC-MS, 1H, 13C NMR, IR, and mass spectra and elemental analysis. All the synthesized compounds were evaluated for their in vitro antibacterial activity against two Gram-positive and two Gram-negative bacterial species, as well as two different strains of antibiotic-resistant E. coli and for antifungal activity against two fungal strains. Some of the compounds have shown potential antimicrobial activity.
Similar content being viewed by others
References
Lüth, A.; Löwe, W. Eur. J. Med. Chem. 2008, 43, 1478.
Špirková, K.; Stankovský, S.; Mrvová, A.; Čipák, Ĺ. Chem. Pap. 1999, 53, 272.
Tiwari, R.; Chhabra, G. Asian J. Chem. 2010, 22, 5981.
Kumar, A.; Sharma, P.; Kumari, P.; Kalal, B. L. Bioorg. Med. Chem. Lett. 2011, 21, 4353.
Bartroli, J.; Turmo, E.; Algueró, M.; Boncompte, E.; Vericat, M. L.; Conte, L.; Ramis, J.; Merlos, M.; García-Rafanell, J.; Forn, J. J. Med. Chem. 1998, 41, 1869.
Balakumar, C.; Lamba, P.; Kishore, D. P.; Narayana, B. L.; Rao, K. V.; Rajwinder, K.; Rao, A. R.; Shireesha, B.; Narsaiah, B. Eur. J. Med. Chem. 2010, 45, 4904.
Wakeling, A. E.; Guy, S. P.; Woodburn, J. R.; Ashton, S. E.; Curry, B. J.; Barker, A. J.; Gibson, K. H. Cancer Res. 2002, 62, 5749.
Nandy, P.; Vishalakshi, M. T.; Bhat, A. R. Indian J. Heterocycl. Chem. 2006, 15, 293.
Kabri, Y.; Azas, N.; Dumètre, A.; Hutter, S.; Laget, M.; Verhaeghe, P.; Gellis, A.; Vanelle, P. Eur. J. Med. Chem. 2010, 45, 616.
Aly, A. A. Chin. J. Chem. 2003, 21, 339.
Saravanan, G.; Alagarsamy, V.; Prakash, C. R. Int. J. Pharm. Pharm. Sci. 2010, 2, Suppl. 4, 83.
Kim, B. M.; Evans, B. E.; Gilbert, K. F.; Hanifin, C. M.; Vacca, J. P.; Michelson, S. R.; Darke, P. L.; Zugay, J. A.; Emini, E. A.; Schleif, W.; Lin, J. H.; Anderson, P. S.; Huff, J. R. Bioorg. Med. Chem. Lett. 1995, 5, 2707.
Askin, D.; Eng, K. K.; Rossen, K.; Purick, R. M.; Wells, K. M.; Volante, R. P.; Reider, P. J. Tetrahedron Lett. 1994, 35, 673.
Patrick, G. L.; Kinsmar, O. S. Eur. J. Med. Chem. 1996, 31, 615.
Hishmat, O. H.; Abdel Galil, F. M.; Farrag, D. S. Pharmazie 1990, 45, 793.
Patel, H. S.; Desai, H. D.; Mistry, H. J. J. Chem. 2004, 1, 93.
Gan, L. L.; Lu, Y. H.; Zhou, C. H. Chin. J. Biochem. Pharm. 2009, 30, 127.
Todorovic, A.; Haskell-Luevano, C. Peptides 2005, 26, 2026.
Kundu, B. Curr. Opin. Drug Discovery Dev. 2003, 6, 815.
Myangar, K. N.; Akhaja, T. N.; Naik, D. R.; Raval, J. P. Chem. Sci. Trans. 2012, 1, 688.
Fournier, J.; Bruneau, C.; Dixneuf, P. H.; Lécolier, S. J. Org. Chem. 1991, 56, 4456.
Abdel-Rahman, H. M.; Morsy, M. A. J. Enzyme Inhib. Med. Chem. 2007, 22, 57.
Domínguéz, J. N.; León, C.; Rodrigues, J.; Gamboa de Domínguez, N.; Gut, J.; Rosenthal, P. J. J. Med. Chem. 2005, 48, 3654.
Suzuki, A. Pure Appl. Chem. 1991, 63, 419.
Suzuki, A. J. Organomet. Chem. 1999, 576, 147.
N. Miyaura, A. Suzuki, Chem. Rev. 1995, 95, 2457.
Kazmi, S. U.; Ali, S. N.; Jamal, S. A.; Atta-ur-Rahman Pak. J. Pharm. Sci. 1991, 4, 113.
Atta-ur-Rehman; Choudhary, M. I.; Thomsen, W. J. Bioassay Techniques for Drug Development; Harwood Academic Publishers: Amsterdam, 2001, p. 16.
Greenwood, D.; Slack, R.; Peutherer, J. Medical Microbiology: A Guide to Microbial Infections: Pathogenesis, Immunity, Laboratory Diagnosis and Control, Edinburgh; ELST Publishers: Edinburgh, 1997, 15th ed., p. 50.
Perez, C.; Pauli, M.; Bazevque, P. Acta Biol. Med. Exp. 1990, 15, 113.
Rasheed, S.; Venkataramana, K.; Chandrasekhar, K.; Fareeda, G.; Naga Raju, C. Arch. Pharm. 2012, 345, 294.
Vasbinder, M. M.; Aquila, B.; Augustin, M.; Chen, H.; Cheung, T.; Cook, D.; Drew, L.; Fauber, B. P.; Glossop, S.; Grondine, M.; Hennessy, E.; Johannes, J.; Lee, S.; Lyne, P.; Mörtl, M.; Omer, C.; Palakurthi, S.; Pontz, T.; Read, J.; Sha, L.; Shen, M.; Steinbacher, S.; Wang, H.; Allan, W.; Minwei, Y. J. Med. Chem. 2013, 56, 1996.
DiMauro, E. F.; Newcomb, J.; Nunes, J. J.; Bemis, J. E.; Boucher, C.; Buchanan, J. L.; Buckner, W. H.; Cee, V. J.; Chai, L.; Deak, H. L.; Epstein, L. F.; Faust, T.; Gallant, P.; Geuns-Meyer, S. D.; Gore, A.; Yan, G.; Henkle, B.; Hodous, B. L.; Hsieh, F.; Huang, X.; Kim, J. L.; Lee, J. H.; Martin, M. W.; Masse, C. E.; McGowan, D. C.; Metz, D.; Mohn, D.; Morgenstern, K.A.; Oliveira-dos-Santos, A.; Patel, V. F.; Powers, D.; Rose, P. E.; Schneider, S.; Tomlinson, S. A.; Tudor, Y.-Y.; Turci, S. M.; Welcher, A. A.; White, R. D.; Zhao, H.; Zhu, L.; Zhu, X. J. Med. Chem. 2006, 49, 5671.
The authors express their gratitude to IISC, Bangalore, for providing spectral data and to DST-PURSE center, Sri Venkateswara University, Tirupati, for evaluating the antibacterial and antifungal activities.
Author information
Authors and Affiliations
Corresponding author
Additional information
Published in Khimiya Geterotsiklicheskikh Soedinenii, 2015, 51(1), 60–66
Rights and permissions
About this article
Cite this article
Babu, D.S., Srinivasulu, D. & Kotakadi, V.S. Synthesis of novel N-aryl-4-[6-(2-fluoropyridin-3-yl)quinazolin-2-yl]-piperazine-1-carboxamide or -carbothioamide derivatives and their antimicrobial activity. Chem Heterocycl Comp 51, 60–66 (2015). https://doi.org/10.1007/s10593-015-1660-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10593-015-1660-2